Public HealthNCT04377581
COVID-19 Health Messaging Efficacy and Its Impact on Public Perception, Anxiety, and Behavior
An observational study of Public Health and Demography, run by Milton S. Hershey Medical Center at 1 site in United States.
Trial summary
Effective communication is a critical component of managing pandemic outbreaks like COVID-19. This study explores COVID-19 related public knowledge, perceptions, belief in public health recommendations, intent to comply with public health recommendations, trust in information sources and preferred information sources. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Public Health, Demography, Pandemics
- How many people
- 18,251 participants
- Where
- 1 siteUnited States
- Study dates
- 9 Apr 2020to 10 Jul 2020
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Human Adults
Who may be able to join
- 18 years of age
Who cannot join
- Below 18 years of age
Trial locations and contacts
1 site in 1 country.
United States1 site
Penn State College of Medicine
Hershey, Pennsylvania, 17033
About this study
Effective communication is a critical component of managing pandemic outbreaks like COVID-19. This study explores COVID-19 related public knowledge, perceptions, belief in public health recommendations, intent to comply with public health recommendations, trust in information sources and preferred information sources. Participants are invited to include detailed free-text answers to make sure their COVID-19 experiences are heard.
Read the detailed description
The survey is available online in 23 languages. Free-text responses in native languages are highly encouraged. A robust global response will not only provide invaluable information to inform clinicians, healthcare institutions and governments about how to optimize the content and venue of COVID-19 messaging, but will help write a Story of COVID in the words and languages of people from all over the world.
- Conditions
- Public Health, Demography, Pandemics, Corona Virus Infection, News, Global Health
- Keywords
- Penn State, CHIME, COVID-19 Messaging Study
- Medical subject headings
- Coronavirus Infections
What is being measured
The primary outcome is the main question the study is designed to answer.
Knowledge and Confidence in Knowledge of COVID-19
Binary knowledge measures (true/false questions pertaining to COVID-19) each have a corresponding 5-point confidence score, the inverse of which generates a weighting variable. Weighted knowledge scores will be analyzed via a generalized linear mixed-methods effects model with a logistic link function and a random effect for the participant, generating a probability of correct response from 0 to 1.0.
Measured: Through study completion, an average of 3 months.
Beliefs about the effectiveness of public health recommendations
Participants are asked, "Do you think that following these CDC recommendations will decrease the spread of COVID-19 in your community?" and select from a 5-point scale, Minimum: 1=certainly not; Maximum: 5 = most certainly.
Measured: Through study completion, an average of 3 months.
Intent to comply with public health recommendations
Participants are asked, "Will you follow these recommendations?" and select from a 5-point scale, Minimum: 1=certainly not; Maximum: 5 = most certainly.
Measured: Through study completion, an average of 3 months.
Perception of Risk of COVID-19 and other health threats
Participants are asked, "How likely is it that you will be diagnosed with any of the following diseases over the next year?" and rate their perceived likelihood of diagnosis for Measles, Flu, Lung Cancer, Ebola and COVID-19 on a 5 point scale. Minimum: 1, very unlikely; Maximum: 5, very likely.
Participants are asked, "How serious do you think infection with any of the following diseases would be (or is) to your own personal health?" and rate their perceived seriousness of diagnosis for Measles, Flu, Lung Cancer, Ebola and COVID-19 on a 5 point scale. Minimum: 1, Not at all Serious; Maximum: 5, Very Serious
Measured: Through study completion, an average of 3 months.
Perceptions of trust in common health information sources
Participants are asked the extent to which they trust common information sources: The World Health Organization, The U.S. Centers for Disease Control and Prevention, the European Commission, the participant's national government, the participant's local government, and the participant's personal healthcare provider. Participants rate on a 5 point scale. Minimum: 1, Not at all; Maximum: 2, Completely. (As these sources are not recognized in all places, participants may select "Not Applicable" in lieu of ranking.
Measured: Through study completion, an average of 3 months.
Single most trusted news source
Participants are asked to identify their single most trusted source of news through selection from a pre-generated list or via free-text.
Measured: Through study completion, an average of 3 months.
Secondary outcomes (4)
Intention to change consumption of news because of COVID-19 (yes/no)
Participants are asked if COVID-19 will change how they consume news (y/n)
Measured: Through study completion, an average of 3 months.
For participants who will change their news consumption, in what way will they change?
Participants who answer, "Yes" to Outcome 7 are asked to provide a free-text response to describe how their consumption of news will change.
Measured: Through study completion, an average of 3 months.
Secondary information sources
Participants are asked to identify all other sources of information via selection from pre-generated menu or free-text.
Measured: Through study completion, an average of 3 months.
Concerns about COVID-19
Free-text response invited to describe their concerns regarding COVID-19.
Measured: Through study completion, an average of 3 months.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 May 2020
- Study start9 Apr 2020
- Primary completion10 Jul 2020
- Study completion10 Jul 2020
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Public HealthStudies of the same condition, open and under way.
- More trials run by Milton S. Hershey Medical CenterThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Ecologic or community
- Time perspective
- Cross-sectional
- Enrolment
- 18,251 participants (actual)
Sponsor and investigators
- Lead sponsor
- Milton S. Hershey Medical Center
- Sponsor type
- University, hospital or other
- Collaborators
- The Huck Institutes of the Life Sciences, The Social Science Research Institute, The Department of Family and Community Medicine, Penn State College of Medicine, The College of Healthcare Information Management Executives (CHIME)
- Responsible party
- Principal investigator, Robert Lennon, Milton S. Hershey Medical Center
- Investigators
- Robert P Lennon, MD, JD, Principal investigator, Penn State College of Medicine
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04377581
- Sponsor's protocol ID
- STUDY00014798
- Status last verified
- Jul 2020
- First submitted
- 30 Apr 2020
- Last updated
- 16 Jul 2020
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 16 Jul 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- COVID-19 Health Messaging Efficacy and Its Impact on Public Perception, Anxiety, and Behavior
- ClinicalTrials.gov ID
- NCT04377581
- Acronym / sponsor ID
- STUDY00014798
- Conditions
- Public Health, Demography, Pandemics, Corona Virus Infection, News, Global Health
- Keywords
- Penn State, CHIME, COVID-19 Messaging Study
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 18,251 participants (actual)
- Lead sponsor
- Milton S. Hershey Medical CenterUniversity, hospital or other
- Collaborators
- The Huck Institutes of the Life Sciences, The Social Science Research Institute, The Department of Family and Community Medicine, Penn State College of Medicine, The College of Healthcare Information Management Executives (CHIME)
- Study start
- 9 Apr 2020 (actual)
- Primary completion
- 10 Jul 2020 (actual)
- Study completion
- 10 Jul 2020 (actual)
- First posted
- 6 May 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Effective communication is a critical component of managing pandemic outbreaks like COVID-19. This study explores COVID-19 related public knowledge, perceptions, belief in public health recommendations, intent to comply with public health recommendations, trust in information sources and preferred information sources. Participants are invited to include detailed free-text answers to make sure their COVID-19 experiences are heard.
Detailed description
The survey is available online in 23 languages. Free-text responses in native languages are highly encouraged. A robust global response will not only provide invaluable information to inform clinicians, healthcare institutions and governments about how to optimize the content and venue of COVID-19 messaging, but will help write a Story of COVID in the words and languages of people from all over the world.
Study design
- Observational model
- Ecologic or community
- Time perspective
- Cross-sectional
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Human Adults
Key inclusion criteria (1 listed)
- 18 years of age
Key exclusion criteria (1 listed)
- Below 18 years of age
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Knowledge and Confidence in Knowledge of COVID-19
Time frame: Through study completion, an average of 3 months.
Binary knowledge measures (true/false questions pertaining to COVID-19) each have a corresponding 5-point confidence score, the inverse of which generates a weighting variable. Weighted knowledge scores will be analyzed via a generalized linear mixed-methods effects model with a logistic link function and a random effect for the participant, generating a probability of correct response from 0 to 1.0.
Beliefs about the effectiveness of public health recommendations
Time frame: Through study completion, an average of 3 months.
Participants are asked, "Do you think that following these CDC recommendations will decrease the spread of COVID-19 in your community?" and select from a 5-point scale, Minimum: 1=certainly not; Maximum: 5 = most certainly.
Intent to comply with public health recommendations
Time frame: Through study completion, an average of 3 months.
Participants are asked, "Will you follow these recommendations?" and select from a 5-point scale, Minimum: 1=certainly not; Maximum: 5 = most certainly.
Perception of Risk of COVID-19 and other health threats
Time frame: Through study completion, an average of 3 months.
Participants are asked, "How likely is it that you will be diagnosed with any of the following diseases over the next year?" and rate their perceived likelihood of diagnosis for Measles, Flu, Lung Cancer, Ebola and COVID-19 on a 5 point scale. Minimum: 1, very unlikely; Maximum: 5, very likely. Participants are asked, "How serious do you think infection with any of the following diseases would be (or is) to your own personal health?" and rate their perceived seriousness of diagnosis for Measles, Flu, Lung Cancer, Ebola and COVID-19 on a 5 point scale. Minimum: 1, Not at all Serious; Maximum: 5, Very Serious
Perceptions of trust in common health information sources
Time frame: Through study completion, an average of 3 months.
Participants are asked the extent to which they trust common information sources: The World Health Organization, The U.S. Centers for Disease Control and Prevention, the European Commission, the participant's national government, the participant's local government, and the participant's personal healthcare provider. Participants rate on a 5 point scale. Minimum: 1, Not at all; Maximum: 2, Completely. (As these sources are not recognized in all places, participants may select "Not Applicable" in lieu of ranking.
Single most trusted news source
Time frame: Through study completion, an average of 3 months.
Participants are asked to identify their single most trusted source of news through selection from a pre-generated list or via free-text.
4 secondary outcomes
Intention to change consumption of news because of COVID-19 (yes/no)
Time frame: Through study completion, an average of 3 months.
For participants who will change their news consumption, in what way will they change?
Time frame: Through study completion, an average of 3 months.
Secondary information sources
Time frame: Through study completion, an average of 3 months.
Concerns about COVID-19
Time frame: Through study completion, an average of 3 months.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Jul 2020.
Related trials for Public Health
Not yet recruiting
Care Burden And Qualıty of Lıfe
Caregiver Burden, Quality of Life
Recruiting
Effectiveness of Enhanced Dialectical Behavior Therapy Skills Training Group for Borderline Personality Disorder
Borderline Personality Disorder (BPD), Dialectical Behavior Therapy
Recruiting
Improving Officer and Civilian Health
Behavior and Behavior Mechanisms, Social Sciences
Recruiting
Assessing the Effectiveness of Heat Adaptation Digital Messages From Primary Care Providers to Their Patients on the Change in Behaviour for Heatwave-related Preparedness
Heathly Subjects, Primary Health Care
Active, not recruitingObservational study
Understanding the Public Impact on Dengue Vaccination Strategies in Yunnan Province, China: A Dynamic Transmission Modeling Study
Dengue Vaccination Strategy Evaluation, Transmission Modeling of Dengue
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Robert P Lennon, MD, JD principal investigator
Penn State College of Medicine
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Public Health and Demography, run by Milton S. Hershey Medical Center at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 16 Jul 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Knowledge and Confidence in Knowledge of COVID-19 (time frame: Through study completion, an average of 3 months.). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jul 2020; AzTrials last refreshed its copy on 7 Nov 2026.